You are here

MPX Bioceutical Corporation

MPX Logo
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
MPX
CSE Index: 
Currency: 


MPX Bioceutical Corporation (formerly known as The Canadian Bioceutical Corporation) is a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets. The issuer’s foundation is built on its profitable operations in Arizona, with two Health 4 Life Dispensaries and well established Melting Point Extracts (MPX) Brand and GreenMart which holds cultivation and production licenses for both the medical and “adult use” sectors in Nevada and is already selling wholesale into the Nevada medical cannabis market. The business has also optioned suitable locations and intends to enter the higher-margin retail arena by applying for at least two dispensary licenses in the Las Vegas market which will operate under the “Health for Life” brand. MPX is currently building-out facilities in Fall River, Massachusetts, which includes a 40,000 square foot property zoned and licensed for cannabis cultivation and a retail dispensary. MPX also manages and has options to purchase three dispensaries and one production facility in Maryland . MPX plans to replicate its success in Arizona to become a dominant multi-state operator.

You are here

MPX Bioceutical Corporation (MPX)

SEDAR Information

Company Info

Address
Yonge Norton Centre
5255 Yonge Street, Suite 701
Toronto, ON M2N 6P4
Canada
Phone
416-840-3725
Fax
877-595-1828
Email
info@mpxbioceutical.com
Website
http://www.mpxbioceutical.com
Listing date
Friday, January 27, 2017
Transfer Agent
Computershare Investor Services Inc.
Auditor
Deloitte LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
404,014,987
Reserved for Issuance: 
249,197,277

Company Officers

W. Scott Boyes, Chairman, President and Chief Executive Officer
Elizabeth M. Stavola, Chief Operating Officer
David McLaren, Chief Financial Officer

Bulletins

06/02/2019

2019-0215 - Delist - MPX Bioceutical Corporation (MPX)

Le 6 février/February 2019

Following the completion of the Arrangement as set out in the Company's management information circular (the "Circular") dated December 11, 2018 and approved by the Company's security holders at the Company's special meeting held on January 15, 2019 (the "Special Meeting"), the common shares of MPX Bioceutical Corporation will be delisted at the market close today February 6, 2019.

Advertisement

Publicité

Latest CSE News

Upcoming Events

06_23_CannaVest_West_Website_V2

CannaVest West

Monday, July 22, 2019 (All day) to Tuesday, July 23, 2019 (All day)
07_25_GritCAMP_2019_Website

GritCAMP 2019

Thursday, July 25, 2019 (All day) to Friday, July 26, 2019 (All day)
08_07_Cannacord_Genuity_39th_Annual_Growth_Conference_Website

Canaccord Genuity 39th Annual Growth Conference

Wednesday, August 7, 2019 (All day) to Thursday, August 8, 2019 (All day)